These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26921268)

  • 1. Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE.
    Gao CC; Liu SY; Wu ZZ; Li TF; Gao GM; Liu ZS; Zheng ZH
    Lupus; 2016 Oct; 25(11):1224-9. PubMed ID: 26921268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences.
    Ruiz-Irastorza G; Egurbide MV; Olivares N; Martinez-Berriotxoa A; Aguirre C
    Rheumatology (Oxford); 2008 Jun; 47(6):920-3. PubMed ID: 18411213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study.
    Muñoz-Ortego J; Torrente-Segarra V; Prieto-Alhambra D; Salman-Monte TC; Carbonell-Abello J
    Scand J Rheumatol; 2012; 41(6):472-5. PubMed ID: 22830580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.
    Eloi M; Horvath DV; Ortega JC; Prado MS; Andrade LE; Szejnfeld VL; de Moura Castro CH
    PLoS One; 2017; 12(1):e0170323. PubMed ID: 28085957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Levels are Associated with Disease Activity and Damage Accrual in Systemic Lupus Erythematosus Patients.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparrós MG; DelOlmo-Romero S; Ortego-Centeno N; Rueda-Medina B
    Biol Res Nurs; 2021 Jul; 23(3):455-463. PubMed ID: 33380211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus.
    Chaiamnuay S; Chailurkit LO; Narongroeknawin P; Asavatanabodee P; Laohajaroensombat S; Chaiamnuay P
    J Clin Rheumatol; 2013 Apr; 19(3):121-5. PubMed ID: 23519176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D insufficiency and deficiency in mexican patients with systemic lupus erythematosus: Prevalence and relationship with disease activity.
    García-Carrasco M; Mendoza-Pinto C; Etchegaray-Morales I; Soto-Santillán P; Jiménez-Herrera EA; Robles-Sánchez V; Rodríguez-Gallegos A; Ramos-Varela A; Muñoz-Guarneros M; Ruiz-Argüelles A
    Reumatol Clin; 2017; 13(2):97-101. PubMed ID: 27084269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Deficiency in Egyptian Systemic Lupus Erythematosus Patients: How Prevalent and Does It Impact Disease Activity?
    Abaza NM; El-Mallah RM; Shaaban A; Mobasher SA; Al-Hassanein KF; Abdel Zaher AA; El-Kabarity RH
    Integr Med Insights; 2016; 11():27-33. PubMed ID: 27695278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.
    Mok CC; Birmingham DJ; Leung HW; Hebert LA; Song H; Rovin BH
    Rheumatology (Oxford); 2012 Apr; 51(4):644-52. PubMed ID: 21719424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus.
    Tay SH; Ho CS; Ho RC; Mak A
    PLoS One; 2015; 10(12):e0144149. PubMed ID: 26636681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and disease activity in systemic lupus erythematosus.
    Ghaussy NO; Sibbitt W; Bankhurst AD; Qualls CR
    J Rheumatol; 2003 Jun; 30(6):1215-21. PubMed ID: 12784392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests.
    Fragoso TS; Dantas AT; Marques CD; Rocha Junior LF; Melo JH; Costa AJ; Duarte AL
    Rev Bras Reumatol; 2012; 52(1):60-5. PubMed ID: 22286646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.
    Abdel Galil SM; El-Shafey AM; Abdul-Maksoud RS; El-Boshy M
    Lupus; 2018 Feb; 27(2):199-209. PubMed ID: 28659049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis.
    Mok CC; Bro ET; Ho LY; Singh RJ; Jannetto PJ
    Clin Rheumatol; 2018 Oct; 37(10):2685-2692. PubMed ID: 30014357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region.
    Salman-Monte TC; Torrente-Segarra V; Almirall M; Corzo P; Mojal S; Carbonell-Abelló J
    Rheumatol Int; 2016 Jul; 36(7):975-85. PubMed ID: 27233506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
    Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage.
    Ruiz-Irastorza G; Gordo S; Olivares N; Egurbide MV; Aguirre C
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1160-5. PubMed ID: 20235208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.